Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Open accessThe DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Telomerase is an enzyme that catalyzes the addition of nucleotides on the ends of chromosomes. Rare loss of function mutations in the gene that encodes the protein component of telomerase (TERT) have been described in patients with idiopathic pulmonary fibrosis (IPF). Here we examine the telomere lengths and pulmonary fibrosis phenotype seen in multiple kindreds with heterozygous TERT mutations. METHODS AND FINDINGS: We have identified 134 individuals with heterozygous TERT mutations from 21 unrelated families. Available medical records, surgical lung biopsies and radiographs were evaluated retrospectively. Genomic DNA isolated from circulating leukocytes has been used to measure telomere lengths with a quantitative PCR assay. We find that telomere lengths of TERT mutation carriers decrease in an age-dependent manner and show progressive shortening with successive generations of mutation inheritance. Family members without TERT mutations have a shorter mean telomere length than normal, demonstrating epigenetic inheritance of shortened telomere lengths in the absence of an inherited TERT mutation. Pulmonary fibrosis is an age-dependent phenotype not seen in mutation carriers less than 40 years of age but found in 60% of men 60 years or older; its development is associated with environmental exposures including cigarette smoking. A radiographic CT pattern of usual interstitial pneumonia (UIP), which is consistent with a diagnosis of IPF, is seen in 74% of cases and a pathologic pattern of UIP is seen in 86% of surgical lung biopsies. Pulmonary fibrosis associated with TERT mutations is progressive and lethal with a mean survival of 3 years after diagnosis. Overall, TERT mutation carriers demonstrate reduced life expectancy, with a mean age of death of 58 and 67 years for males and females, respectively. CONCLUSIONS: A subset of pulmonary fibrosis, like dyskeratosis congenita, bone marrow failure, and liver disease, represents a "telomeropathy" caused by germline mutations in telomerase and characterized by short telomere lengths. Family members within kindreds who do not inherit the TERT mutation have shorter telomere lengths than controls, demonstrating epigenetic inheritance of a shortened parental telomere length set-point.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In IPF patients with telomerase mutations, the mean age of onset is 51 years, although IPF can manifest as late as the ninth decade of life70,71.”
From The telomere syndromes (2012) · cites this paper as [70]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
From The telomere syndromes (2012) · cites this paper as [70]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · cited 1×
“hTERT is highly expressed in germ cells, cells with proliferative potential and immortalized cancer cells[3,4,5].”
Background(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · cited 1×
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundThe RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · cited 1×
“The human enzyme consists of both a functional RNA (hTR) and a reverse transcriptase protein component (hTERT)[1,2].”
BackgroundTelomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650 · cited 1×
“Evidence of this is seen by the progressive shortening of telomere lengths of human mononuclear leukocytes with age[6] and several diseases of inherited telomerase dysfunction[7].”
BackgroundTelomere length measurement by a novel monochrome multiplex quantitative PCR method
Cawthon, R. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1027 · Cited by 1,410 · cited 1×
“Multiplexed quantitative polymerase chain reaction (PCR) determination of telomere lengths were performed on a RotorGene real-time PCR system (Qiagen) as described[21] with 0.”
MethodTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · cited 1×
“Heterozygous loss-offunction mutations in TERT have been found in up to 15% of kindreds with the familial pulmonary fibrosis[17,18] and in 1–3% of sporadic cases[19,20].”
BackgroundIncidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 1×
“However, unlike DKC, IPF is much more common with its prevalence increasing with age to 65 cases per 100,000 for those 75 years or older [16].”
BackgroundSelf-citationHeiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976 · cited 1×
“Most DKC patients have mutations in the X-linked DKC1 gene, which encodes dyskerin[8]; fewer patients have mutations in TERC, which encodes hTR[9].”
BackgroundThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 1×
“Most DKC patients have mutations in the X-linked DKC1 gene, which encodes dyskerin[8]; fewer patients have mutations in TERC, which encodes hTR[9].”
Background
Cited by
Items 201–300 of 376
Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs
van Moorsel, C. H. M., Hoffman, T. W., van Batenburg, A. A., Klay, D., van der Vis, J. J., & Grutters, J. C. (2015) · BioMed Research International · doi:10.1155/2015/304186 · Cited by 20
Calado, R. T. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397898-1.00008-6 · Cited by 20
“Most patients are affected after age 60 years, males are predominantly affected, and the median survival is 3 years after diagnosis.(24) In addition, while telomerase mutations are found in a minority of IPF patients, most of them have short telomeres for their age.”
BackgroundInfluentialHoffman, T. W., van der Vis, J. J., Biesma, D. H., Grutters, J. C., & van Moorsel, C. H. M. (2022) · Respirology · doi:10.1111/resp.14264 · Cited by 20
Idiopathic Pulmonary Fibrosis and Telomeres
Mulet, A., & Signes‐Costa, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11236893 · Cited by 23
Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
Papiris, S. A., Kannengiesser, C., Borie, R., Kolilekas, L., Kallieri, M., Apollonatou, V., Ba, I., Nathan, N., Bush, A., Griese, M., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12122928 · Cited by 20
Pirfenidone Therapy for Familial Pulmonary Fibrosis: A Real-Life Study
Bennett, D., Refini, R. M., Valentini, M. L., Fui, A., Fossi, A., Pieroni, M., Mazzei, M. A., & Rottoli, P. (2019) · Lung · doi:10.1007/s00408-019-00203-w · Cited by 17
Wang, P., & Xu, Z. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01645-w · Cited by 17
Genetic testing in interstitial lung disease: An international survey
Terwiel, M., Borie, R., Crestani, B., Galvin, L., Bonella, F., Fabre, A., Froidure, A., Griese, M., Grutters, J. C., Johannson, K. A., et al. (2022) · Respirology · doi:10.1111/resp.14303 · Cited by 20
“In the evaluation of lung transplantation 135 (49) 71 (23) 11 (12) NA”
BackgroundCottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Respiratory Medicine and Research · doi:10.1016/j.resmer.2022.100948 · Cited by 25
Usual interstitial pneumonia (UIP): a clinically significant pathologic diagnosis
Mukhopadhyay, S. (2022) · Modern Pathology · doi:10.1038/s41379-022-01053-3 · Cited by 20
Air pollution and alveolar health
Sofia, C., Parkin, J. G. H., Bell, J. A., Dean, L. S. N., Edgeway, L. J., Sayer, L. N., Easton, N. H. C., Davies, D. E., Marshall, B. G., Holgate, S. T., et al. (2025) · European Respiratory Review · doi:10.1183/16000617.0280-2024 · Cited by 25
Telomerase activation in the treatment of aging or degenerative diseases: a systematic review
Prieto-Oliveira, P. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03929-x · Cited by 17
Stockklausner, C., Raffel, S., Klermund, J., Bandapalli, O. R., Beier, F., Brümmendorf, T. H., Bürger, F., Sauer, S. W., Hoffmann, G. F., Lorenz, H., et al. (2015) · Aging · doi:10.18632/aging.100835 · Cited by 18
“Members of the telomerase complex such as TERC, TERT or DKC1 play fundamental roles in aging processes [4-7].”
BackgroundUsual Interstitial Pneumonia: Typical and Atypical High-Resolution Computed Tomography Features
Lynch, D. A., & Huckleberry, J. (2013) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2013.10.003 · Cited by 15
Pneumocystosis revealing immunodeficiency secondary toTERCmutation
Borie, R., Kannengiesser, C., de Fontbrune, F. S., Boutboul, D., Tabèze, L., Brunet‐Possenti, F., Lainey, É., Debray, M., Cazes, A., & Crestani, B. (2017) · European Respiratory Journal · doi:10.1183/13993003.01443-2017 · Cited by 15
Telomerase gene variants and telomere shortening in patients with silicosis or asbestosis
Fan, Y., Zheng, C., Wu, N., Li, Y., Huang, X., & Ye, Q. (2020) · Occupational and Environmental Medicine · doi:10.1136/oemed-2020-107046 · Cited by 15
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis
Cocconcelli, E., Tonelli, R., Abbati, G., Marchioni, A., Castaniere, I., Pelizzaro, F., Russo, F. P., Vegetti, A., Balestro, E., Pietrangelo, A., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02376-2 · Cited by 17
Popper, H., Stacher‐Priehse, E., Brčić, L., & Nerlich, A. (2021) · Rheumatology International · doi:10.1007/s00296-021-05002-2 · Cited by 14
Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?
Lettieri, S., Oggionni, T., Lancia, A., Bortolotto, C., & Stella, G. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062882 · Cited by 16
The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD
Platenburg, M. G. J. P., van der Vis, J. J., Kazemier, K. M., Grutters, J. C., & van Moorsel, C. H. M. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.106760 · Cited by 15
Sivley, R. M., Sheehan, J. H., Kropski, J. A., Cogan, J. D., Blackwell, T. S., Phillips, J. A., Bush, W. S., Meiler, J., & Capra, J. A. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2010-z · Cited by 13
Stanel, S. C., Callum, J., & Rivera‐Ortega, P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1232655 · Cited by 15
“Hematological abnormalities, such as anemia (17–27%), macrocytosis (24–41%) or thrombocytopenia (8–54%) may be associated to ILD (16, 17).”
BackgroundBordas-Martínez, J., Miedema, J., Mathot, B. J., Seghers, L., Galjaard, R. H., Raaijmakers, M. H. G. P., Aalbers, A. M., Wijsenbeek, M. S., Molina‐Molina, M., & Hellemons, M. E. (2024) · JHLT Open · doi:10.1016/j.jhlto.2024.100054 · Cited by 13
The Role of Ubiquitination and SUMOylation in Telomere Biology
Zalzman, M., Meltzer, W. A., Portney, B. A., Brown, R. A., & Gupta, A. (2019) · Current Issues in Molecular Biology · doi:10.21775/cimb.035.085 · Cited by 18
Ishii, K., & Young, N. S. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.07.002 · Cited by 19
Sack, C. S., WOJDYLA, D. M., MacMurdo, M. G., Gassett, A. J., Kaufman, J. D., Raghu, G., Redlich, C. A., Li, P., Olson, A. L., Leonard, T. B., et al. (2024) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202404-382oc · Cited by 13
Self-citationBrain imaging features of children with Hoyeraal‐Hreidarsson syndrome
Zhang, M., Cao, Y., Wu, H., & Li, H. (2021) · Brain and Behavior · doi:10.1002/brb3.2079 · Cited by 13
Lung Fibrosis, Premature Graying, and Macrocytosis
Chambers, D. C., Clarke, B. E., McGaughran, J. M., & Garcia, C. K. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201112-2175im · Cited by 12
Self-citationBorie, R., Kannengiesser, C., Dupin, C., Debray, M., Cazes, A., & Crestani, B. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2020.104024 · Cited by 13
Pulmonary Alveolar Proteinosis Revealing a Telomerase Disease
Marchand-Adam, S., Diot, B., Magro, P., Muret, A. D., Guignabert, C., Kannengiesser, C., Londoño‐Vallejo, A., Drašković, I., Toutain, A., & Diot, P. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201301-0010le · Cited by 12
Garcia, C. K. (2015) · CHEST Journal · doi:10.1378/chest.15-0077 · Cited by 12
Self-citationHartwig, F. P., & Collares, T. V. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.003 · Cited by 11
Genomic Landscape of Meningiomas
Wang, J. Z., Nassiri, F., Mawrin, C., & Zadeh, G. M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-29750-2_11 · Cited by 13
Fibrotic hypersensitivity pneumonitis
Pérez, E. R. F., & Brown, K. K. (2014) · Current Respiratory Care Reports · doi:10.1007/s13665-014-0094-0 · Cited by 13
Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases
Dvorak, L. A., Vassallo, R., Kirmani, S., Johnson, G. B., Hartman, T. E., Tazelaar, H. D., Leslie, K. O., Colby, T. V., Cockcroft, D. W., Churg, A., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.10.003 · Cited by 11
“A recent study reported decreased telomere lengths in a cohort of 134 individuals with heterozygous TERT mutations, and they also found pulmonary fibrosis to be an age-dependent phenotype [9].”
BackgroundInfluentialFamilial Interstitial Pneumonia
Talbert, J. L., Schwartz, D. A., & Steele, M. P. (2014) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000034 · Cited by 13
“In 1 report, family members who did not inherit a TERT mutation had shorter telomere lengths than controls, demonstrating that factors other than mutations in TERT (such as mutations in other genes, epigenetic inheritance, or a shared environment) can affect telomere length.(46) A large genome-wide association study C…”
BackgroundSkeletal and Joint Manifestations of Primary Immunodeficiency Diseases
Gharib, A. (2016) · SOJ Immunology · doi:10.15226/2372-0948/4/1/00145 · Cited by 11
“In autosomal dominant DKC due to Telomerase Reverse Transcriptase (TERT) deficiency, 26% have osteoporosis/ osteopenia and 3% scoliosis [51].”
BackgroundGruenwald, A., Neururer, M., Eidenhammer, S., Nerlich, A. G., & Popper, H. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155432 · Cited by 12
Rare genetic interstitial lung diseases: a pictorial essay
Borie, R., Berteloot, L., Kannengiesser, C., Griese, M., Cazes, A., Crestani, B., Hadchouel, A., & Debray, M. (2024) · European Respiratory Review · doi:10.1183/16000617.0101-2024 · Cited by 12
Epigenetic inheritance of telomere length obscures identification of causative PARN locus
Xing, C., & Garcia, C. K. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103685 · Cited by 11
Self-citationInterstitial Lung Diseases and the Impact of Gender
Karampitsakos, Τ., Παπαϊωάννου, Ο., Katsaras, M., Sampsonas, F., & Τzouvelekis, Α. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.04.011 · Cited by 10
Measuring relative telomere length: Is tissue an issue?
Gramatges, M. M., & Bertuch, A. A. (2010) · Aging · doi:10.18632/aging.100236 · Cited by 10
“A higher proportion of single nucleotide variants within specific telomerase-associated genes, such as TERT and TERC, which encode the catalytic and RNA subunits of telomerase, respectively, have been described in cases with disease compared with a control population [14-19].”
BackgroundA Phase I Randomized, Controlled, Clinical Trial of Valganciclovir in Idiopathic Pulmonary Fibrosis
Blackwell, T. S., Hewlett, J. C., Mason, W. R., Martin, S., Greco, J. D., Ding, G., Wu, P., LANCASTER, L. H., Loyd, J. E., Dudenhofer, R. B., et al. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202102-108oc · Cited by 11
Clustering of lung diseases in the family of interstitial lung disease patients
Terwiel, M., Grutters, J. C., & van Moorsel, C. H. M. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01927-x · Cited by 12
Sandbo, N. K. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_8 · Cited by 13
The MNS16A VNTR polymorphism of the TERT gene in bladder cancer
Diler, S. B., Polat, F., & Bingöl, G. (2019) · Urology Research and Practice · doi:10.5152/tud.2019.19005 · Cited by 12
“might also cause serious clinical phenotypes in syndromes with bone marrow failure and increase cancer frequency.[8,12]”
BackgroundCottin, V., Bonniaud, P., Cadranel, J. L., Crestani, B., Jouneau, S., Marchand-Adam, S., Nunès, H., Wémeau-Stervinou, L., Bergot, E., Blanchard, É., et al. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.01.014 · Cited by 14
Lin, Q., Zheng, Z., Ni, H., Xu, Y., & Nie, H. (2024) · Gene · doi:10.1016/j.gene.2024.148502 · Cited by 8
Clinical, radiological and histopathological features of patients with familial pulmonary fibrosis
Jaula, H., Mattila, L., Lappi‐Blanco, E., Salonen, J., Vähänikkilä, H., Ahvenjärvi, L., Moilanen, J. S., Kuismin, O., Harju, T. H., & Kaarteenaho, R. L. (2024) · Respiratory Research · doi:10.1186/s12931-024-02864-5 · Cited by 12
“In the study of Diaz de Leon et al., 39 CT scans of patients with TERT gene variants with pulmonary fibrosis were evaluated; 74% had a typical UIP pattern, and the other patterns were consistent with UIP without honeycombing and atypical UIP [31].”
BackgroundResultInfluentialDuckworth, A., Jackson, L. M., Green, H., Khan, A., Wang, C., Condescu, A., Hawkes, G., Noth, I., Martínez, F. J., Raghu, G., et al. (2026) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(25)00405-9 · Cited by 10
Self-citationNelson, N. E., Feurstein, S. K., Niaz, A., Truong, J. Q., Holien, J. K., Lucas, S. E. M., Fairfax, K. A., Dickinson, J. L., & Bryan, T. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.11.021 · Cited by 11
Dyskeratosis Congenita and the Telomere Biology Disorders
Dodson, L. M., & Bertuch, A. A. (2018) · Pediatric oncology · doi:10.1007/978-3-319-61421-2_6 · Cited by 8
Alfred, T., Ben‐Shlomo, Y., Cooper, R., Hardy, R., Cooper, C. C., Deary, I. J., Elliott, J., Gunnell, D., Harris, S. E., Mika Kivimaki, B., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00687.x · Cited by 8
“This would indicate that the lack of association observed in this study is not because of the choice of common polymor- phism within the TERT-CLPTM1L locus, although mutations in the region may influence telomere length (Diaz de Leon et al., 2010).”
BackgroundMethodProspects for Rejuvenation of Aged Tissue by Telomerase Reactivation
Cox, L. S., & Mason, P. A. (2010) · Rejuvenation Research · doi:10.1089/rej.2010.1140 · Cited by 10
Molecular Diagnosis and Precision Therapeutic Approaches for Telomere Biology Disorders
Perona, R., Iarriccio, L., Pintado‐Berninches, L., Rodríguez-Centeno, J., Manguán-García, C., Garcia, E., López‐Ayllón, B. D., & Sastre, L. (2016) · InTech eBooks · doi:10.5772/65353 · Cited by 12
“IPF patients that carry mutations in telomere-related genes can also present extra-pulmonary manifestations related to telomere biology disorders such as bone marrow failure including red blood cells, single lineage cytopenias or aplastic anemia [164].”
IPF and CPFE—The Two Different Entities or Two Different Presentations of the Same Disease?
Kwiatkowska, S. (2017) · Advances in respiratory medicine · doi:10.5603/arm.a2017.0049 · Cited by 9
Actualités dans les pneumopathies interstitielles idiopathiques en 2016
Debray, M., Borie, R., Danel, C. J., Khalil, A., Majlath, M., & Crestani, B. (2016) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2016.09.001 · Cited by 8
Treatable traits in interstitial lung disease: a narrative review
Harrison, M., Lawler, C., Lake, F., Navaratnam, V. V., Fermoyle, C. C., Moodley, Y. P., & Corte, T. J. (2025) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666251335774 · Cited by 8
Assayag, D., Adegunsoye, A., Khor, Y. H., Bonella, F., Borie, R., Buendía-Roldán, I., Chaudhuri, N., Gibson, K. F., Johannson, K. A., Kaminski, N., et al. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202509-2336st · Cited by 7
“Among patients with telomere-related pathogenic variants, male patients are younger than females at diagnosis (105), and their telomere lengths are signi fi cantly shorter, suggesting that females may be protected from telomere shortening, which is itself a risk factor for IPF (106).”
Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review
Ding, D., Gao, R., Xue, Q., Luan, R., & Yang, J. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.80358 · Cited by 8
“assessed 134 patients with f-IPF from 21 families with PF (all with telomerase TERT mutations) and found that 18% of the patients had heterozygous TERT mutations, covering 18 mutation sites, and some patients may have several telomerase mutations (57).”
BackgroundMolecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease
Newton, C. A., & Herzog, E. L. (2021) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2021.03.011 · Cited by 7
CSP7 Protects Alveolar Epithelial Cells by Targeting p53 -Fibrinolytic Pathways During Lung Injuries
Puthusseri, B., Bhagavath, A. K., Korir, D., Shetty, R. R., Johnson, G. A., Stankowska, D. L., Konduru, N. V., Tang, H., Bolla, S., Criner, G. J., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2023-0453oc · Cited by 8
Telomerase and non-Telomerase Mechanisms of Telomere Maintenance
Morrish, T. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73734 · Cited by 8
Airway Telomere Length in Lung Transplant Recipients
Mackintosh, J. A., Yerkovich, S. T., Tan, M. E., Samson, L. D., Hopkins, P. M.-A., & Chambers, D. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658062 · Cited by 7
“Determination of Telomere Length by PCR The relative telomere length in airway cells was determined by quantitative PCR based on the T/S ratio as previously described (14, 15).”
MethodDokal, I. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405546-9.00011-x · Cited by 6
Kliszczak, M., Moralli, D., Jankowska, J. D., Bryjka, P., Meem, L. S., Goncalves, T., Hester, S. S., Fischer, R., Clynes, D., & Green, C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1175069 · Cited by 6
“…in this manuscript could explain why patients carrying FAM111B mutations suffer from pulmonary dysfunction as fibrosis of the lungs strongly correlates with short telomeres (Armanios et al., 2007; Tsakiri et al., 2007; Alder et al., 2008; Cronkhite et al., 2008; Diaz de Leon et al., 2010).”
BackgroundCerri, S., Manzini, E., Nori, O., Pacchetti, L., Rossi, L., Turchiano, M. G., Samarelli, A. V., Raineri, G., Andrisani, D., Gozzi, F., et al. (2024) · Medicina · doi:10.3390/medicina60121967 · Cited by 8
“Mutations in TRG were initially identified in patients with dyskeratosis congenita (DKC) and later in those suffering from bone marrow failure syndromes, pulmonary fibrosis, and liver disease [13].”
Çepni, E., Satkın, N. B., Moheb, L. A., Rocha, M. E., & Kayserili, H. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62602 · Cited by 8
Sampsonas, F., Bosgana, P., Bravou, V., Tzouvelekis, A., Dimitrakopoulos, F.-I. D., & Kokkotou, E. (2024) · Genes · doi:10.3390/genes15070934 · Cited by 6
“HRCT is the diagnostic modality of choice in order to diagnose suspicious lesions in IPF patients, since it is also routinely, annually, or biannually used to monitor patients with ILDs.”
BackgroundMaus, M. T. K., Groen, K., van der Vis, J. J., Grutters, J. C., & van Moorsel, C. H. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020674 · Cited by 5
Khatami, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-66475-0_3 · Cited by 6
Wilcox, M. E., Rivera, M. P., Sassoon, C. S. H., Ware, L. B., Wunsch, H., & Herridge, M. S. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201206-033tt · Cited by 6
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease
Perrotta, F., Zamparelli, S. S., D’Agnano, V., Montella, A., Fomez, R., Pagliaro, R., Schiattarella, A., Cazzola, M., Bianco, A., & Mariniello, D. F. (2024) · Biomedicines · doi:10.3390/biomedicines12071384 · Cited by 4
Telomere biology disorders and hepatic disease
Pirzada, S. A., Aleyadeh, W., Fathma, S., Koh, C., Plessier, A., Kleiner, D. E., & Heller, T. (2025) · Seminars in Hematology · doi:10.1053/j.seminhematol.2026.05.004 · Cited by 4
Herrera, F. E., & Sferco, S. J. (2018) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25573 · Cited by 4
“23 In summary, concerning the catalytic activity of hTERT, the point mutations of residues K902, R631, and K626 appear to be as crucial as the mutations in any of the aspartic acid residues.”
BackgroundGuérin, C., Crestani, B., Dupin, C., Kawano-Dourado, L. B., Ba, I., Kannengiesser, C., & Borie, R. (2022) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2022.03.011 · Cited by 5
Elbadry, M. I., Tawfeek, A., Hirano, T., El‐Mokhtar, M. A., Kenawey, M., Helmy, A. M., Ogawa, S., Zulf Mughal, M., & Nannya, Y. (2023) · British Journal of Haematology · doi:10.1111/bjh.19176 · Cited by 4
Idiopathic Pulmonary Fibrosis Phenotypes
Nathan, S. D. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-682-5_10 · Cited by 4
Syndromes Associated with Telomere Shortening
Nag, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88792 · Cited by 7
Groen, K., van der Vis, J. J., van Batenburg, A. A., Kazemier, K. M., Grutters, J. C., & van Moorsel, C. H. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032790 · Cited by 5
Samarelli, A. V., Tonelli, R., Raineri, G., Bruzzi, G., Andrisani, D., Gozzi, F., Marchioni, A., Costantini, M., Fabbiani, L., Genovese, F., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1275346 · Cited by 5
The Genetics of Interstitial Lung Diseases
Borie, R., Guen, P. L., Ghanem, M., Taillé, C., Mathai, S. K., Dieudé, P., Kannengiesser, C., & Crestani, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11453-9 · Cited by 4
Hanibuchi, M., Ogino, H., Sato, S., & Nishioka, Y. (2024) · The Journal of Medical Investigation · doi:10.2152/jmi.71.9 · Cited by 3
Koike, T., Yamamoto, S., Shibata, M., Otsuka, K., Sugishita, Y., Kaneko, R., Kawabata, N., Fujita, S., Akiyama, K., Toyama, D., et al. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31757 · Cited by 4
Genetic factors for ILD—the path of precision medicine
Raghu, G., Torres, J. M., & Bennett, R. L. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00071-7 · Cited by 5
Self-citationGenetic Interstitial Lung Disease
Garcia, C. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48024-6.00001-x · Cited by 4
Self-citationAltered Nucleotide Insertion Mechanisms of Disease-Associated TERT Variants
Welfer, G. A., Borin, V. A., Cortez, L. M., Opresko, P. L., Agarwal, P. K., & Freudenthal, B. (2023) · Genes · doi:10.3390/genes14020281 · Cited by 3
“The A255V TERT variant is associated with IPF, BMF, and cancer [45–47,68].”
BackgroundInfluentialHan, M. K., Shteinberg, M., Assayag, D., Schleich, F., Pengo, M. F., Scicluna, V. M., Lombardi, C., Barrecheguren, M., & Jara‐Palomares, L. (2024) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2024.10.009 · Cited by 3
A 49-Year-Old Man With Cirrhosis and Pulmonary Fibrosis
Rajaram, P., Little, B. P., Norvell, J. P., McLemore, M. L., & Veeraraghavan, S. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.06.010 · Cited by 3
Garcia, C. K. (2012) · Proceedings of the American Thoracic Society · Cited by 3
Self-citationVerduyn, M., Rigaud, M., & Dromer, C. (2017) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2017.07.004 · Cited by 4
ILDgenDB: integrated genetic knowledge resource for interstitial lung diseases (ILDs)
Mishra, S., Shah, M. I., Sarkar, M. S., Asati, N., & Rout, C. (2018) · Database · doi:10.1093/database/bay053 · Cited by 3
“The role of mutation in above genes was also verified in smoking-related ILDs (22).”
BackgroundCui, B., Chen, Y., Ma, X., Yin, G., & Xie, Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1414064/v1 · Cited by 3
Use of Next-Generation Sequencing to Support the Diagnosis of Familial Interstitial Pneumonia
Gigante, A. R., Tinoco, E. M., Fonseca, A., Marques, I. D., Sanches, A., Salgueiro, N., Nogueira, C., Campainha, S., & Neves, S. (2023) · Genes · doi:10.3390/genes14020326 · Cited by 2
“Of note, the transmission of the telomere length is independent of the transmission of the mutation, and thus, it is possible to inherit short telomeres (and disease risk) without inheriting a mutation; therefore, this assessment can complement the genetic study [2,9,15,26,27].”
BackgroundBiomarkers and genetic predictors of hypersensitivity pneumonitis
Трушенко, Н. В., Nikolenko, A. M., Suvorova, O., & Avdeev, S. N. (2024) · PULMONOLOGIYA · doi:10.18093/0869-0189-2024-34-6-896-903 · Cited by 2
Vilstrup, E., Prior, T. S., Kreuter, M., Wuyts, W. A., Molina‐Molina, M., Wijsenbeek, M. S., Morais, A., Tzouvelekis, A., Ryerson, C. J., Caro, F. M., et al. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03532-0 · Cited by 5
Pott, J., Höing, A.-S., Volk, A. E., Well, L., Beier, F., Lebrecht, D., Harbaum, L., Klose, H. F. E., & Oqueka, T. (2025) · Chronic Respiratory Disease · doi:10.1177/14799731251370357 · Cited by 2
Methods for telomere length measurement: an update on current technologies and emerging approaches
Makarova, J. A., Belova, U. D., Zvereva, M. I., Shkurnikov, M. Y., & Tonevitsky, A. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1725112 · Cited by 5
Aging as a multifactorial disorder with two stages
Gems, D., Carver, A., & Zhao, Y. (2025) · Aging · doi:10.18632/aging.206339 · Cited by 3
“For example, mutations in various genes linked to b-amyloid processing lead to early onset (familial) Alzheimer's disease (Chouraki and Seshadri, 2014), and mutation of the protein component of telomerase (TERT) leads to increased levels of idiopathic pulmonary fibrosis (IPF) (Diaz de Leon et al., 2010).”
Carlier, F. M., Planté-Bordeneuve, T., Froidure, A., Graux, C., van Dievoet, M., van Moorsel, C. H. M., & Hoffman, T. W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1718107 · Cited by 7
Metadata
- Authors
- Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., & Garcia, C. K.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- SUNY Upstate Medical University (US)
- University of Washington Medical Center (US)
- University of Chicago (US)
- Corresponding author
- Garcia, Christine Kim
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-05-19
- Volume
- 5
- Issue
- 5
- Pages
- e10680
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2873288
- OpenAlex
- W2035774221
- Cited by
- 377
- References
- 35
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 22 · 2023: 22 · 2022: 27 · 2021: 24 · 2020: 24 · 2019: 27 · 2018: 34 · 2017: 23 · 2016: 22 · 2015: 23 · 2014: 24 · 2013: 31 · 2012: 25
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Doris Duke Charitable Foundation
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL093096)
- National Center for Research Resources (K23RR020632)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- telomere length, idiopathic pulmonary fibrosis, TERT mutation, telomerase, telomeropathies, epigenetic inheritance, usual interstitial pneumonia, cigarette smoking, dyskeratosis congenita, germline mutations, age-dependent phenotype, survival
- MeSH terms
- Adult, Aged, Aged, 80 and over, Family, Female, Heterozygote, Humans, Male, Middle Aged, Mutation, Pedigree, Phenotype, Pulmonary Fibrosis, Radiography, Respiratory Function Tests, Smoking, Telomere, Telomerase, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.